US Patent Issued to Deciphera Pharmaceuticals on June 3 for "Methods of treating gastrointestinal stromal tumors" (Massachusetts Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,373, issued on June 3, was assigned to Deciphera Pharmaceuticals LLC (Waltham, Mass.).

"Methods of treating gastrointestinal stromal tumors" was invented by Rodrigo Ruiz Soto (Waltham, Mass.), Oliver Rosen (Waltham, Mass.) and Jama Pitman (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof."

The patent was filed on June 21, 2024, under Application No. 18/750,032.

*For further information, in...